Scientific Research An Academic Publisher
OPEN ACCESS
Add your e-mail address to receive free newsletters from SCIRP.
Select Journal AA AAD AAR AASoci AAST ABB ABC ABCR ACES ACS ACT AD ADR AE AER AHS AID AiM AIT AJAC AJC AJCC AJCM AJIBM AJMB AJOR AJPS ALAMT ALC ALS AM AMI AMPC ANP APD APE APM ARS ARSci AS ASM BLR CC CE CellBio ChnStd CM CMB CN CRCM CS CSTA CUS CWEEE Detection EMAE ENG EPE ETSN FMAR FNS GEP GIS GM Graphene GSC Health IB ICA IIM IJAA IJAMSC IJCCE IJCM IJCNS IJG IJIDS IJIS IJMNTA IJMPCERO IJNM IJOC IJOHNS InfraMatics JACEN JAMP JASMI JBBS JBCPR JBiSE JBM JBNB JBPC JCC JCDSA JCPT JCT JDAIP JDM JEAS JECTC JEMAA JEP JFCMV JFRM JGIS JHEPGC JHRSS JIBTVA JILSA JIS JMF JMGBND JMMCE JMP JPEE JQIS JSBS JSEA JSEMAT JSIP JSS JSSM JST JTR JTST JTTs JWARP LCE MC ME MI MME MNSMS MPS MR MRC MRI MSA MSCE NJGC NM NR NS OALib OALibJ ODEM OJA OJAB OJAcct OJAnes OJAP OJApo OJAppS OJAPr OJAS OJBD OJBIPHY OJBM OJC OJCB OJCD OJCE OJCM OJD OJDer OJDM OJE OJEE OJEM OJEMD OJEpi OJER OJF OJFD OJG OJGas OJGen OJI OJIC OJIM OJINM OJL OJM OJMC OJMetal OJMH OJMI OJMIP OJML OJMM OJMN OJMP OJMS OJMSi OJN OJNeph OJO OJOG OJOGas OJOp OJOph OJOPM OJOTS OJPathology OJPC OJPChem OJPed OJPM OJPP OJPS OJPsych OJRA OJRad OJRD OJRM OJS OJSS OJSST OJST OJSTA OJTR OJTS OJU OJVM OPJ POS PP PST PSYCH SAR SCD SGRE SM SN SNL Soft SS TEL TI UOAJ VP WET WJA WJCD WJCMP WJCS WJET WJM WJNS WJNSE WJNST WJV WSN YM
More>>
Ozols, R.F. (2005) Treatment Goals in Ovarian Cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 15, 3-11. http://dx.doi.org/10.1111/j.1525-1438.2005.15351.x
has been cited by the following article:
TITLE: Current Possible Drug Therapies for Ovarian Cancer
AUTHORS: Jungyeob Seoung, Young-Han Park, Chaechun Rhim, Sungju Kim
KEYWORDS: Ovarian Cancer, Intraperitoneal Chemotherapy, Targeting Therapy
JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.13, November 7, 2014
ABSTRACT: Ovarian cancer is the most aggressive gynecologic cancer of the heterogenous phenotypes. Development of the new chemotherapeutic agents and drug delivery mode makes better outcomes for patient treatments. Optimal cytoreductive therapy followed by molecular targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is a hot therapeutic concept in ovarian cancers. In our review, we will introduce recent therapeutic advances in epithelial ovarian cancer patients.
Related Articles:
The burden of gynecological cancer management in Northern Nigeria
Adekunle O. Oguntayo, Marliya Zayyan, Mattew Akpar, Abimbola O. D. Kolawole, Sunday A. Adewuyi
DOI: 10.4236/ojog.2013.38115 3,616 Downloads 4,968 Views Citations
Pub. Date: October 30, 2013
Change in Preoperative Nervousness: A Randomized Controlled Trial in Gynecological Cancer Patients
Marianne K. Thygesen, René De Pont Christensen, Lone Hedemand, Ole Mogensen
DOI: 10.4236/health.2016.83025 4,939 Downloads 5,545 Views Citations
Pub. Date: February 5, 2016
Groundless Research Published on the International Journal of Plant Sciences
Xin Wang
DOI: 10.4236/vp.2020.64020 93 Downloads 501 Views Citations
Pub. Date: November 27, 2020
Erratum to “Inflammation and Its Role in Prostate Cancer” [Journal of Cancer Therapy 5 (2014) 836-844]
Rakesh K. Mishra, Ashutosh K. Tewari
DOI: 10.4236/jct.2015.61011 3,123 Downloads 3,697 Views Citations
Pub. Date: January 28, 2015
Primarily Outcome of Laparoscopic Hysterectomy for Early-Stage Malignant Gynecological Cancer of Unselected Cases in Five Years
Juan Qin, Guolin Song, Juntao Wang, Anwei Lu
DOI: 10.4236/ijcm.2014.521172 2,886 Downloads 3,597 Views Citations
Pub. Date: December 22, 2014
